Fig. 1From: Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based studyStandard estimates of the average marginal effects on colonoscopy/FOBT, mammography and PSA testing utilization. FOBT = fecal occult blood testing; PCG = Pharmacy-based Cost GroupBack to article page